Drugs / Pandemic influenza vaccine (GSK1119711A)-formulation 2
Pandemic influenza vaccine (GSK1119711A)-formulation 2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00430521 | Feb 2007 → Oct 2008 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pandemic influenza vaccine (GSK1119711A)-formulation 2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00430521 ↗ |
| Modality | Vaccine | “Pandemic influenza vaccine” NCT00430521 ↗ |
| Route | Intramuscular | “intramuscular injection” NCT00430521 ↗ |